Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic/Myeloproliferative Diseases
Interventions: BIOLOGICAL: filgrastim|BIOLOGICAL: recombinant flt3 ligand|BIOLOGICAL: recombinant human thrombopoietin|BIOLOGICAL: recombinant interleukin-3|PROCEDURE: in vitro-treated peripheral blood stem cell transplantation
Sponsor: Northwestern University